Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection
View ORCID ProfileAriel Israel, Yotam Shenhar, Ilan Green, View ORCID ProfileEugene Merzon, Avivit Golan-Cohen, View ORCID ProfileAlejandro A Schäffer, View ORCID ProfileEytan Ruppin, View ORCID ProfileShlomo Vinker, View ORCID ProfileEli Magen
doi: https://doi.org/10.1101/2021.08.19.21262111
Ariel Israel
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
MD, PhDYotam Shenhar
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
MDIlan Green
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
2Department of Family Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
MDEugene Merzon
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
2Department of Family Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
MDAvivit Golan-Cohen
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
2Department of Family Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
MDAlejandro A Schäffer
3Cancer Data Science Laboratory, National Cancer Institute, Bethesda, MD USA
PhDEytan Ruppin
3Cancer Data Science Laboratory, National Cancer Institute, Bethesda, MD USA
MD, PhDShlomo Vinker
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
2Department of Family Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
MD, MHAEli Magen
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
4Medicine C Department, Clinical Immunology and Allergy Division, Barzilai University Medical Center, Ben Gurion University of the Negev, Israel
MD
Article usage
Posted August 22, 2021.
Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection
Ariel Israel, Yotam Shenhar, Ilan Green, Eugene Merzon, Avivit Golan-Cohen, Alejandro A Schäffer, Eytan Ruppin, Shlomo Vinker, Eli Magen
medRxiv 2021.08.19.21262111; doi: https://doi.org/10.1101/2021.08.19.21262111
Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection
Ariel Israel, Yotam Shenhar, Ilan Green, Eugene Merzon, Avivit Golan-Cohen, Alejandro A Schäffer, Eytan Ruppin, Shlomo Vinker, Eli Magen
medRxiv 2021.08.19.21262111; doi: https://doi.org/10.1101/2021.08.19.21262111
Subject Area
Subject Areas
- Addiction Medicine (280)
- Allergy and Immunology (580)
- Anesthesia (141)
- Cardiovascular Medicine (1968)
- Dermatology (188)
- Emergency Medicine (336)
- Epidemiology (11128)
- Gastroenterology (631)
- Genetic and Genomic Medicine (3204)
- Geriatric Medicine (310)
- Health Economics (568)
- Health Informatics (2054)
- Health Policy (864)
- Hematology (311)
- HIV/AIDS (686)
- Medical Education (319)
- Medical Ethics (92)
- Nephrology (339)
- Neurology (3005)
- Nursing (167)
- Nutrition (466)
- Oncology (1566)
- Ophthalmology (478)
- Orthopedics (189)
- Otolaryngology (267)
- Pain Medicine (204)
- Palliative Medicine (57)
- Pathology (404)
- Pediatrics (916)
- Primary Care Research (357)
- Public and Global Health (5620)
- Radiology and Imaging (1104)
- Respiratory Medicine (765)
- Rheumatology (342)
- Sports Medicine (291)
- Surgery (351)
- Toxicology (48)
- Transplantation (159)
- Urology (133)